V

Voronoi Inc
KOSDAQ:310210

Watchlist Manager
Voronoi Inc
KOSDAQ:310210
Watchlist
Price: 209 500 KRW -2.78% Market Closed
Market Cap: 3.9T KRW

Net Margin
Voronoi Inc

-1 280.4%
Current
-509%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 280.4%
=
Net Income
-42.9B
/
Revenue
3.4B

Net Margin Across Competitors

No Stocks Found

Voronoi Inc
Glance View

Market Cap
3.8T KRW
Industry
Biotechnology

Voronoi, Inc. engages in the manufacture of novel kinase inhibitors and target protein degrader drugs. The company is headquartered in Incheon, Incheon. The company went IPO on 2022-06-24. The firm is principally engaged in the technology transfer of new drug candidates prior to electroclinical clinical trials. The firm is principally engaged in the research and development of kinase inhibitor as well as others. In addition, the Company is also engaged in the building and supply of new drug development platforms based on artificial intelligence (AI) and research results.

Intrinsic Value
30 933.27 KRW
Overvaluation 85%
Intrinsic Value
Price
V
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 280.4%
=
Net Income
-42.9B
/
Revenue
3.4B
What is the Net Margin of Voronoi Inc?

Based on Voronoi Inc's most recent financial statements, the company has Net Margin of -1 280.4%.

Back to Top